fda semaglutide shortage lawsuit As of February 21, 2025, the updated its drug list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A FDA confirms tirzepatide shortage is

However, individuals taking these medicationsespecially those with pre-existing diabetes or eye conditionsshould undergo regular eye exams and monitor for any changes in vision

Sacks, D

In a multivariable mixed effects model that defined semaglutide dose as a time-dependent covariate, we examined interaction terms with time to determine whether rates of percentage BMI change varied depending on patient characteristics or dose

During energy restriction, the body requires fuel and will mobilise stored reserves to meet its needs

0% Weight Loss per STEP Trials STEP trial studied FDA-approved Wegovy (semaglutide 2.4mg), not compounded semaglutide